Sarcoma / 2013 / Article / Tab 1

Clinical Study

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Table 1

Patient characteristics.

Total35
Age (median, range)53 (27–76)

(%)

Sex
 Male16 (45.7%)
 Female19 (54.3%)
ECOG performance status at baseline
 01 (2.8%)
 130 (85.7%)
 24 (11.4%)
Histology
 De-differentiated liposarcoma22 (62.8%)
 Synovial sarcoma7 (20%)
 Myxoid/round-cell liposarcoma3 (8.5%)
 Other3 (8.5%)
Previous chemotherapy
 Chemotherapy naive23 (65.7%)
 Ifosfamide-containing regimen9 (25.7%)
 Nonifosfamide-containing regimen3 (8.5%)
Previous surgery
 Yes23 (65.7%)
 No12 (34.3%)
Baseline creatinine clearance
(Cockroft-Gault formula)
 Median97 mL/min
(51.9–215.8)
Baseline albumin
 Median35 g/L (21–43)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.